Fiduciary Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$914K Buy
2,525
+81
+3% +$27.7K 0.1% 124
2026
Q1
$860K Sell
2,444
-229
-9% -$81.6K 0.11% 118
2025
Q4
$875K Buy
2,673
+28
+1% +$8.88K 0.12% 113
2025
Q3
$746K Buy
2,645
+20
+0.8% +$5.8K 0.12% 113
2025
Q2
$763K Buy
2,625
+180
+7% +$51K 0.14% 100
2025
Q1
$688K Buy
2,445
+1,342
+122% +$396K 0.15% 100
2024
Q4
$289K Sell
1,103
-68
-6% -$20.2K 0.06% 204
2024
Q3
$372K Sell
1,171
-1
-0.1% -$327 0.09% 157
2024
Q2
$390K Buy
+1,172
New +$344K 0.09% 133

Other funds holding AMGN

Fiduciary Financial Group's AMGN Position: Q2 2026 in Review

Fiduciary Financial Group increased its Amgen (AMGN) stake by 3.3% in Q2 2026, buying an estimated $27.7K and bringing the position to 2,525 shares worth $914K. The position accounts for 0.1% of the portfolio, ranked #124.

Fiduciary Financial Group first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fiduciary Financial Group held 2,525 shares of Amgen worth $914K as of Q2 2026.
  • Fiduciary Financial Group bought 81 Amgen shares in Q2 2026, an estimated $27.7K.
  • Amgen made up 0.1% of Fiduciary Financial Group's portfolio in Q2 2026, its #124 holding.
  • Fiduciary Financial Group first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fiduciary Financial Group's 13F filing for Q2 2026, filed 10 Jul 2026.